Literature DB >> 25851244

Ventilator-associated pneumonia rates after introducing selective digestive tract decontamination.

Ronny M Schnabel1, Johannes B J Scholte, Kim E H M Van Der Velden, Paul M H J Roekaerts, Dennis C J J Bergmans.   

Abstract

The incidence of ventilator-associated pneumonia (VAP) before and after the introduction of selective oral decontamination (SOD) only and selective digestive tract decontamination (SDD) in a general intensive care population was examined. SOD as standard of care was introduced in December 2010 and SDD, including SOD, in January 2012 for all patients with an expected length of intensive care unit (ICU) stay of at least 48 h. The diagnosis of VAP was based on clinical criteria and quantitative cultures of bronchoalveolar lavage fluid. A total of 4945 mechanically ventilated patients accounting for 37 554 ventilator days in the period from 2005 to 2013 were analyzed. The incidence of VAP per 1000 ventilator days declined significantly from 4.38 ± 1.64 before to 1.64 ± 0.43 after introduction of SOD/SDD (p = 0.007). Implementation of SOD/SDD as standard of care in ICUs may thus be effective in preventing VAP.

Entities:  

Keywords:  Bronchoalveolar lavage; antibacterial agents; critical care; decontamination; preventive measures

Mesh:

Substances:

Year:  2015        PMID: 25851244     DOI: 10.3109/23744235.2015.1031172

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  7 in total

Review 1.  Pneumonia After Cardiovascular Surgery: Incidence, Risk Factors and Interventions.

Authors:  Dashuai Wang; Yang Lu; Manda Sun; Xiaofan Huang; Xinling Du; Zhouyang Jiao; Fuqiang Sun; Fei Xie
Journal:  Front Cardiovasc Med       Date:  2022-06-30

2.  Long-term use of selective digestive decontamination in an ICU highly endemic for bacterial resistance.

Authors:  Catalina Sánchez-Ramírez; Silvia Hípola-Escalada; Miriam Cabrera-Santana; María Adela Hernández-Viera; Liliana Caipe-Balcázar; Pedro Saavedra; Fernando Artiles-Campelo; Nayra Sangil-Monroy; Carlos Federico Lübbe-Vázquez; Sergio Ruiz-Santana
Journal:  Crit Care       Date:  2018-05-30       Impact factor: 9.097

3.  Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China.

Authors:  Yu Wang; Rong Zhang; Wei Liu
Journal:  Infect Drug Resist       Date:  2018-11-13       Impact factor: 4.003

4.  Risk factors for postoperative pneumonia after cardiac surgery: a prediction model.

Authors:  Dashuai Wang; Xiaofan Huang; Hongfei Wang; Sheng Le; Han Yang; Feng Wang; Xinling Du
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

5.  Ventilator-associated Pneumonia caused by commensal oropharyngeal Flora; [corrected] a retrospective Analysis of a prospectively collected Database.

Authors:  Johannes B J Scholte; Johan I M van der Velde; Catharina F M Linssen; Helke A van Dessel; Dennis C J J Bergmans; Paul H M Savelkoul; Paul M H J Roekaerts; Walther N K A van Mook
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

6.  Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.

Authors:  Ronny Schnabel; Rianne Fijten; Agnieszka Smolinska; Jan Dallinga; Marie-Louise Boumans; Ellen Stobberingh; Agnes Boots; Paul Roekaerts; Dennis Bergmans; Frederik Jan van Schooten
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

7.  Selective digestive decontamination solution used as "lock therapy" prevents and eradicates bacterial biofilm in an in vitro bench-top model.

Authors:  María Jesús Pérez-Granda; Beatriz Alonso; Ricardo Zavala; María Consuelo Latorre; Javier Hortal; Rafael Samaniego; Emilio Bouza; Patricia Muñoz; María Guembe
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-23       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.